Free Trial

Venus Concept (VERO) Competitors

$0.56
-0.03 (-5.04%)
(As of 05/23/2024 ET)

VERO vs. TMDIF, TNON, STSS, INVO, QNRX, IONM, VAPO, GMVDF, AEMD, and RSLS

Should you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include Titan Medical (TMDIF), Tenon Medical (TNON), Sharps Technology (STSS), INVO Bioscience (INVO), Quoin Pharmaceuticals (QNRX), Assure (IONM), Vapotherm (VAPO), G Medical Innovations (GMVDF), Aethlon Medical (AEMD), and ReShape Lifesciences (RSLS). These companies are all part of the "surgical & medical instruments" industry.

Venus Concept vs.

Venus Concept (NASDAQ:VERO) and Titan Medical (NASDAQ:TMDIF) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, community ranking, valuation, risk, earnings, profitability, media sentiment and institutional ownership.

87.4% of Venus Concept shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 51.4% of Venus Concept shares are owned by company insiders. Comparatively, 0.0% of Titan Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Venus Concept received 34 more outperform votes than Titan Medical when rated by MarketBeat users.

CompanyUnderperformOutperform
Venus ConceptOutperform Votes
34
65.38%
Underperform Votes
18
34.62%
Titan MedicalN/AN/A

Venus Concept has a beta of 0.65, indicating that its stock price is 35% less volatile than the S&P 500. Comparatively, Titan Medical has a beta of 1.23, indicating that its stock price is 23% more volatile than the S&P 500.

In the previous week, Venus Concept and Venus Concept both had 1 articles in the media. Venus Concept's average media sentiment score of 0.35 beat Titan Medical's score of 0.00 indicating that Venus Concept is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Venus Concept
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Titan Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Venus Concept
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Titan Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Titan Medical has a net margin of 0.00% compared to Venus Concept's net margin of -51.00%. Titan Medical's return on equity of 126.94% beat Venus Concept's return on equity.

Company Net Margins Return on Equity Return on Assets
Venus Concept-51.00% N/A -38.96%
Titan Medical N/A 126.94%80.01%

Titan Medical has lower revenue, but higher earnings than Venus Concept. Venus Concept is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Venus Concept$76.35M0.05-$37.25M-$6.68-0.08
Titan Medical$17.63M0.22$6.95M$0.050.68

Summary

Titan Medical beats Venus Concept on 8 of the 13 factors compared between the two stocks.

Get Venus Concept News Delivered to You Automatically

Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VERO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VERO vs. The Competition

MetricVenus ConceptSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$3.59M$3.78B$5.07B$7.98B
Dividend YieldN/A2.11%2.82%3.92%
P/E Ratio-0.0810.69135.8316.35
Price / Sales0.0573.542,489.7873.69
Price / CashN/A49.9536.2131.80
Price / Book-0.165.105.404.56
Net Income-$37.25M$6.24M$106.18M$213.88M
7 Day Performance-10.94%-2.96%-2.16%-1.58%
1 Month Performance-30.02%-1.00%1.73%2.30%
1 Year Performance-77.93%18.62%4.05%6.48%

Venus Concept Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TMDIF
Titan Medical
0 of 5 stars
$0.04
flat
N/A-77.5%$4.56M$17.63M1.004Gap Up
TNON
Tenon Medical
1.5745 of 5 stars
$0.97
+10.2%
$3.00
+209.2%
-53.8%$3.62M$2.93M-0.1021Gap Down
STSS
Sharps Technology
0 of 5 stars
$0.22
flat
N/A-74.0%$3.45MN/A0.0057News Coverage
Gap Up
INVO
INVO Bioscience
0 of 5 stars
$1.12
-8.2%
N/A-86.6%$3.07M$3.02M-0.0925Positive News
Gap Down
QNRX
Quoin Pharmaceuticals
2.6964 of 5 stars
$0.78
-1.3%
$4.00
+414.3%
-86.9%$2.87MN/A-0.114News Coverage
IONM
Assure
0.1736 of 5 stars
$0.42
flat
$4.00
+845.4%
-49.9%$2.84M$250,000.000.00127Gap Up
VAPO
Vapotherm
0 of 5 stars
$0.89
-11.0%
N/A-82.2%$5.53M$67.60M-0.10182News Coverage
High Trading Volume
GMVDF
G Medical Innovations
0 of 5 stars
$0.01
flat
N/AN/A$2.63M$4.42M0.0084Gap Up
AEMD
Aethlon Medical
1.1215 of 5 stars
$0.85
-14.1%
$10.00
+1,076.3%
-86.8%$2.23M$570,000.00-0.1715Analyst Forecast
Gap Up
High Trading Volume
RSLS
ReShape Lifesciences
0 of 5 stars
$0.17
flat
N/A-93.4%$2.19M$8.68M0.0029

Related Companies and Tools

This page (NASDAQ:VERO) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners